The ergothioneine transporter controls and indicates ergothioneine activity - A review

Preventive Medicine

Volumn 54, Issue SUPPL., 2012, Pages

  Gründemann, Dirk ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antioxidants; Ergothioneine; Ergothioneine transporter

Indexed keywords

AMINO ACID; AMPHOLYTE; CARRIER PROTEIN; CD71 ANTIGEN; MEPYRAMINE; MESSENGER RNA; ORGANIC CATION TRANSPORTER 1; QUINIDINE; SODIUM; THIAMAZOLE; THIONEINE; TRANSFERRIN RECEPTOR; VERAPAMIL;

AMINO ACID SEQUENCE; ANTIOXIDANT ACTIVITY; CATALYST; CELL MEMBRANE; CELLULAR DISTRIBUTION; CYTOSOL; ERYTHROCYTE; GLYCOSYLATION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; ANTIOXIDANTS; ERGOTHIONEINE; HUMANS; MODELS, ANIMAL; ORGANIC CATION TRANSPORT PROTEINS;

EID: 84860873283     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2011.12.001     Document Type: Review

References (27)

1. Bacher P., Giersiefer S., Bach M., Fork C., Schömig E., Gründemann D. Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: gain-of-function by interchange of selected amino acids. Biochim. Biophys. Acta 2009, 1788:2594-2602.
2. Chaudiere J., Ferrari-Iliou R. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem. Toxicol. 1999, 37:949-962.
3. Fisher S.A., Hampe J., Onnie C.M., et al. Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease. Hum. Mutat. 2006, 27:778-785.
4. Grigat S., Harlfinger S., Pal S., et al. Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochem. Pharmacol. 2007, 74:309-316.
5. Gründemann D., Harlfinger S., Golz S., et al. Discovery of the ergothioneine transporter. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5256-5261.
6. Hartman P.E. Ergothioneine as Antioxidant, Methods in Enzymology 1990, Vol. 186:310-318. Academic Press.
7. Kato Y., Kubo Y., Iwata D., et al. Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1. Pharm. Res. 2010, 27:832-840.
8. Lamhonwah A.M., Tein I. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem. Biophys. Res. Commun. 2006, 345:1315-1325.
9. Lin Z., Nelson L., Franke A., et al. OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease. J. Crohns Colitis 2010, 4:132-138.
10. Mann T. The Biochemistry of Semen 1954, Methuen, John Wiley, London, New York.
11. Mann T., Leone E. Studies on the metabolism of semen. VIII. Ergothioneine as a normal constituent of boar seminal plasma; purification and crystallization; site of formation and function. Biochem. J. 1953, 53:140-148.
12. Melville D.B. Ergothioneine. Vitam. Horm. 1958, 17:155-204.
13. Nakamura T., Yoshida K., Yabuuchi H., Maeda T., Tamai I. Functional characterization of ergothioneine transport by rat organic cation/carnitine transporter Octn1 (slc22a4). Biol. Pharm. Bull. 2008, 31:1580-1584.
14. Nikodemus D., Lazić D., Bach M., et al. Paramount levels of ergothioneine transporter SLC22A4 mRNA in boar seminal vesicles and cross-species analysis of ergothioneine and glutathione in seminal plasma. J. Physiol. Pharmacol. 2011, 62:411-419.
15. Paul B.D., Snyder S.H. The unusual amino acid l-ergothioneine is a physiologic cytoprotectant. Cell Death Differ. 2010, 17:1134-1140.
16. Peltekova V.D., Wintle R.F., Rubin L.A., et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 2004, 36:471-475.
17. Pfeiffer C., Bauer T., Surek B., Schömig E., Gründemann D. Cyanobacteria produce high levels of ergothioneine. Food Chem. 2011, 129:1766-1769.
18. Santiago J.L., Martinez A., de la Calle H., et al. Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study. BMC Med. Genet. 2006, 7:54.
19. Schömig E., Lazar A., Gründemann D. Extraneuronal monoamine transporter and organic cation transporters 1 and 2 - a review of transport efficiency. Handbook of Experimental Pharmacology - Neurotransmitter Transporters 2006, 151-180. Springer, Heidelberg. H.H. Sitte, M. Freissmuth (Eds.).
20. Tamai I., Yabuuchi H., Nezu J., et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 1997, 419:107-111.
21. Tamai I., Ohashi R., Nezu J., et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 1998, 273:20378-20382.
22. Tamai I., Ohashi R., Nezu J.I., et al. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J. Biol. Chem. 2000, 275:40064-40072.
23. Tamai I., Nakanishi T., Kobayashi D., et al. Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol. Pharm. 2004, 1:57-66.
24. Tokuhiro S., Yamada R., Chang X., et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 2003, 35:341-348.
25. Waller S., Tremelling M., Bredin F., Godfrey L., Howson J., Parkes M. Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut 2006, 55:809-814.
26. Wu X., George R.L., Huang W., et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim. Biophys. Acta 2000, 1466:315-327.
27. Yabuuchi H., Tamai I., Nezu J.-I., et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J. Pharmacol. Exp. Ther. 1999, 289:768-773.